−£21.61m
vs Dec 2024Active09843076Private limited companyAbingdon
T-CYPHER BIO LIMITED
Significant control: T Cypher Bio Holdings Ltd (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for T-Cypher Bio Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does T-Cypher Bio Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
T-CYPHER BIO LIMITED is an active private limited company (company number 09843076) incorporated on 27 October 2015, registered in Abingdon. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£21.61m and cash of £5.20m, with 37 employees on average. Net assets fell 42% on the prior period (−£15.19m). Across the last 3 periods on record the net-asset trend is falling.
Peer position · net assets
By net assets it sits in the bottom quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- T Cypher Bio Holdings Ltd
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Oxford Sciences Innovation Plc
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 27 October 201510 yrs ago
- Next accounts due
- 30 September 2027in 339 days
- Confirmation statement due
- 10 November 2026in 15 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
05
Financials
£5.20m
−56%vs Dec 2024Not reported
37
+16%vs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£21.61m | £5.20m | £2.09m | £1.10m | — | — | 37 |
| 31 December 2024 | −£15.19m | £11.87m | £1.77m | £1.18m | — | — | 32 |
| 31 December 2023 | −£9.81m | £5.86m | £1.28m | £858k | — | — | 23 |
Current ratio6.63Current assets ÷ creditors within one year
Cash per employee£141kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-21,613,340 at 31 December 2025
- Net assets down 25% or more on the prior period-42.3% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 6.63
- Cash at bank of £50,000 or moreCash £5,201,966
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 27 October 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 339 days
- Confirmation statement duein 15 days
- Accounts period endNet liabilities £21.61m · small accounts
- Accounts period endNet liabilities £15.19m · small accounts
- Accounts period endNet liabilities £9.81m · small accounts
- Incorporated
08
Similar companies in Oxford
- OPTELLUM LTDOxford · inc. Oct 2015
- ESTRYX PHARMA LIMITEDWitney · inc. Nov 2015
- OXFORD ENDOVASCULAR LIMITEDOxford · inc. Sept 2015
- THE GENOME FOUNDRY LIMITEDOxford · inc. Sept 2015
- TAILORED CLINICAL RESEARCH SOLUTIONS LIMITEDOxford · inc. Dec 2015
- GYLDEN PHARMA LIMITEDAbingdon · inc. Jan 2016
All companies incorporated on 27 October 2015 · in Oct 2015.
09
Reminders for T-CYPHER BIO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.